Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mexilitene use in pregnancy.

A R Gregg1, P G Tomich

  • 1Loyola University Medical Center, Department of Obstetrics and Gynecology, Maywood, IL 60153.

Journal of Perinatology : Official Journal of the California Perinatal Association
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decisions on second pregnancy after uterus transplantation and timing for removal of the uterus-DUETS (Dallas UtErus Transplant Study).

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Contextual factors influencing the implementation of the obstetrics hemorrhage initiative in Florida.

Journal of perinatology : official journal of the California Perinatal Association·2016
Same author

Prenatal diagnosis of sub-microscopic partial trisomy 10q using chromosomal microarray analysis in a phenotypically abnormal fetus with normal karyotype.

Journal of neonatal-perinatal medicine·2016
Same author

An endothelial nitric oxide synthase gene polymorphism is associated with preeclampsia.

Hypertension in pregnancy·2002
Same author

Clinical value of postnatal autopsy and genetics consultation in fetal death.

American journal of medical genetics·2001
Same author

Analysis of guanidinoacetate and creatine by isotope dilution electrospray tandem mass spectrometry.

Clinica chimica acta; international journal of clinical chemistry·2001

Mexilitene effectively treated arrhythmias during pregnancy. No adverse effects were observed in breastfed infants, but careful dosage monitoring is crucial.

Area of Science:

  • Cardiology
  • Pharmacology
  • Maternal-Fetal Medicine

Background:

  • Class 1b antiarrhythmic mexilitene use in pregnancy is limited.
  • Mitral valve prolapse can be associated with arrhythmias.

Observation:

  • A pregnant patient with mitral valve prolapse received mexilitene for symptomatic premature ventricular contractions.
  • Maternal serum and cord blood mexilitene levels were measured at delivery.

Findings:

  • Mexilitene may be a viable treatment for pregnant patients with refractory arrhythmias.
  • No adverse effects were noted in infants whose mothers breastfed while taking mexilitene.

Implications:

  • Mexilitene shows potential for treating pregnant women with arrhythmias unresponsive to standard therapies.

Related Experiment Videos

  • Close monitoring of mexilitene dosage during pregnancy and postpartum is essential for therapeutic drug levels.